Brochure | May 4, 2020

Diploid Growth And Production Media For Vaccine Production

Diploid SRM

Gibco Diploid Serum-Reduced Medium helps reduce risk, cost and the danger of adventitious agents

Now you can transition to a reduced-serum medium for human diploid cells without sacrificing cell growth or virus expression. Gibco diploid serum-reduced medium (SRM) is a combination of two media to support vaccine manufacture under serum-reduced or serum-free conditions with human diploid cells such as MRC-5, Wl-38, KMB17, 2BS, as well as chicken embryo fibroblasts (CEF). When culturing human diploid cells such as MRC-5, WI38, and KMB17 cell growth may be accomplished with 1–2% serum. Additionally, CEFs may be cultured serum-free. Virus production can then be conducted under serum-free conditions without the addition of serum or albumin.

VIEW THE BROCHURE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: